A deleterious germline mutation in the PALB2 (Partner and Localizer of BRCA2) gene, which accounts for 3–4% of familial pancreatic cancer cases, was identified in a 53‐year‐old female patient.15 This evidence concerns the gene BRCA2 and pancreatic neoplasm.